DBV Technologies (DBVT) Shares Repurchased (2016 - 2024)
DBV Technologies (DBVT) reported Shares Repurchased of -$33000.0 for Q2 2024, down 180.49% year-over-year from $41000.0 in Q3 2023, and up 46.77% on a QoQ basis from -$62000.0 in Q1 2024.
DBV Technologies (DBVT) has 9 years of Shares Repurchased data on file, last reported at -$33000.0 in Q2 2024.
- Quarterly Shares Repurchased fell 180.49% year-over-year to -$33000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$276000.0 (down 113.95% YoY) and the FY2023 annual result came in at -$154000.0, down 225.2% from the prior year.
- Shares Repurchased climbed to -$33000.0 in Q2 2024 per DBVT's latest filing, from -$62000.0 in the prior quarter.
- Across five years, Shares Repurchased topped out at $578000.0 in Q1 2021 and bottomed at -$997000.0 in Q3 2021.
- The 5-year median for Shares Repurchased is $6500.0 (2023), against an average of -$28055.6.
- The widest annual swing landed in 2022, when Shares Repurchased jumped 298.33%; it then tumbled 700.0% in 2023.
- Tracing DBVT's Shares Repurchased over 5 years: stood at $203000.0 in 2020, then soared by 167.49% to $543000.0 in 2021, then sank by 104.79% to -$26000.0 in 2022, then plunged by 700.0% to -$208000.0 in 2023, then jumped by 84.13% to -$33000.0 in 2024.
- Per Business Quant, the three latest DBVT Shares Repurchased figures stand at -$33000.0 (Q2 2024), -$62000.0 (Q1 2024), and -$208000.0 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 336.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 794.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -33,000.00 |
| Jun 30, 2024 | -33,000.00 |
| Mar 31, 2024 | -62,000.00 |
| Mar 31, 2024 | -62,000.00 |
| Dec 31, 2023 | -208,000.00 |
| Dec 31, 2023 | -208,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | -26,000.00 |
| Dec 31, 2022 | -26,000.00 |
| Sep 30, 2022 | -130,000.00 |
| Sep 30, 2022 | -130,000.00 |
| Jun 30, 2022 | 239,000.00 |
| Jun 30, 2022 | 239,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Dec 31, 2021 | 543,000.00 |
| Dec 31, 2021 | 543,000.00 |
| Sep 30, 2021 | -997,000.00 |
| Sep 30, 2021 | -997,000.00 |
| Jun 30, 2021 | 60,000.00 |
| Jun 30, 2021 | 60,000.00 |
| Mar 31, 2021 | 578,000.00 |
| Mar 31, 2021 | 578,000.00 |
| Dec 31, 2020 | 203,000.00 |
| Dec 31, 2020 | 203,000.00 |
| Sep 30, 2020 | -410,000.00 |
| Sep 30, 2020 | -410,000.00 |
| Jun 30, 2020 | 56,000.00 |
| Jun 30, 2020 | 56,000.00 |
| Mar 31, 2020 | -412,000.00 |
| Mar 31, 2020 | -412,000.00 |
| Sep 30, 2019 | 166,909.50 |
| Sep 30, 2019 | 166,909.50 |
| Dec 31, 2018 | -546,728.89 |
| Dec 31, 2018 | -546,728.89 |
| Sep 30, 2018 | 32,567.62 |
| Sep 30, 2018 | 32,567.62 |
| Jun 30, 2018 | -14,321.33 |
| Jun 30, 2018 | -14,321.33 |
| Dec 31, 2017 | -29,435.81 |
| Dec 31, 2017 | -29,435.81 |
| Dec 31, 2016 | -58,305.11 |
| Dec 31, 2016 | -58,305.11 |